MY
MYNZ
MAINZ BIOMED N.V.
No data for this timeframe.
Vol
Reddit Sentiment83° Bullish
Recent Activity
May 8, 2026
Insider
NATAN DAVID sold 137,141 shares
Director @ $0.00 ($0.00)
Apr 22, 2026
Insider
Lazar David E. sold 1,000,000 shares
Chief Executive Officer @ $1.50 ($1.5M)
Apr 22, 2026
Insider
Lazar David E. sold 1,000,000 shares
Chief Executive Officer @ $1.50 ($1.5M)
Mar 11, 2026
other
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
Analyst Ratings
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 14, 2025 | Maxim Group | INITIATE | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
| Apr 12, 2024 | Cantor Fitzgerald | REITERATE | Neutral |
| Mar 6, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Nov 21, 2023 | Cantor Fitzgerald | DOWNGRADE | Overweight → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-2.86 | $-2.86 — $-2.86 | 87% YoY | 1 |
| Next FY | $-1.51 ▼ -11.9% | $-1.51 — $-1.51 | 47% YoY | 1 |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 8, 2026 | NATAN DAVID | A | $0.00 |
| Apr 22, 2026 | Lazar David | A | $1.5M |
| Apr 22, 2026 | Lazar David | A | $1.5M |
| Feb 13, 2026 | Lazar David | A | $0.00 |
| Feb 13, 2026 | Lazar David | A | $0.00 |
Reddit Sentiment
83°▼
Bullish
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 8, 2026 | NATAN DAVID | Director | A | 137,141 | $0.00 | $0.00 |
| Apr 22, 2026 | Lazar David E. | Chief Executive Officer | A | 1,000,000 | $1.50 | $1.5M |
| Apr 22, 2026 | Lazar David E. | Chief Executive Officer | A | 1,000,000 | $1.50 | $1.5M |
| Feb 13, 2026 | Lazar David E. | Director | A | 1,000,000 | $0.00 | $0.00 |
| Feb 13, 2026 | Lazar David E. | Director | A | 1,000,000 | $0.00 | $0.00 |
| Feb 13, 2026 | Lazar David E. | Director | A | 1,000,000 | $0.00 | $0.00 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$-2.86 | $-2.86 | $-2.86 | 87.2% | +0.0% | 1↑ 0↓ | $0.0B | 7.0% | 1 |
| Next FY 2026-12-31 |
$-1.51 | $-1.51 | $-1.51 | 47.2% | -11.9% | — | $0.0B | -4.1% | 1 |
| Next Q 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
4 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 4 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 14, 2025 | Maxim Group | INITIATE | — | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Apr 12, 2024 | Cantor Fitzgerald | REITERATE | — | Neutral |
| Mar 6, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Nov 21, 2023 | Cantor Fitzgerald | DOWNGRADE | Overweight | Neutral |
| Nov 20, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Sep 26, 2023 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Sep 22, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Sep 14, 2023 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Aug 22, 2023 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Aug 18, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| May 18, 2023 | Cantor Fitzgerald | MAINTAIN | Overweight | Overweight |
| Apr 27, 2023 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Mar 30, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Feb 16, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Feb 10, 2023 | JonesTrading | INITIATE | — | Buy |
| Oct 25, 2022 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Jun 21, 2022 | HC Wainwright & Co. | INITIATE | — | Buy |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
83°
Bullish
Bearish
Neutral
Bullish
11 mentions
10 bullish
0 bearish
10 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 5, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Mar 4, 2026 | 2 | 67° Warm | 2 | 0 | 2 |
| Mar 4, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 4, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 4, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Clinical Breakthrough and Catalysts for MYNZ
▲ 1
💬 1
⚡ 0.5
MYNZ testing the $0.80 level after yesterday's +9% move
▲ 1
💬 1
⚡ 0.5
Microcap Biotech With Clinical and Global Tailwinds
▲ 1
💬 0
⚡ 0.5
A major cancer center is pushing blood-based CRC screening as an annual exam idea, and that is a real category signal for MYNZ
▲ 1
💬 1
⚡ 0.5
33% revenue growth and a full strategic reset at MYNZ
▲ 1
💬 0
⚡ 0.5
MYNZ Chart Behavior - Quiet Before Catalyst Storm?
▲ 1
💬 0
⚡ 0.5
MYNZ is a $10.5M biotech with multiple catalysts
▲ 1
💬 0
⚡ 0.5
Mar 11, 2026
other
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors